CMBA
ARVN icon

C.M. Bidwell & Associates’s Arvinas ARVN Stock Holding History

C.M. Bidwell & Associates’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-53
Closed -$562 – 502
2026
Q1 		$562 Buy
+53
New +$656 ﹤0.01% 461
2025
Q3 		– Sell
-520
Closed -$3.83K – 491
2025
Q2 		$3.83K Hold
520
– – ﹤0.01% 347
2025
Q1 		$3.65K Buy
+520
New +$8.15K ﹤0.01% 344

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

C.M. Bidwell & Associates's ARVN Position: Q2 2026 in Review

C.M. Bidwell & Associates sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 53 shares — an estimated $562 sold.

C.M. Bidwell & Associates first reported a position in ARVN in Q1 2025 and held it in 3 quarters. The position peaked at $3.83K in Q2 2025. 201 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • C.M. Bidwell & Associates reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 53 Arvinas shares in Q2 2026, an estimated $562.
  • C.M. Bidwell & Associates first reported a position in Arvinas in Q1 2025 and held it in 3 quarters.
  • C.M. Bidwell & Associates's Arvinas position peaked at $3.83K in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.